Rare diseases
Investigational molecules
Locations
Ul. Ul. Jana Dlugosza 4, 51-162 Wroclaw, Poland
Centrum Badan Klinicznych Piotr Napora Lekarze sp.p. in Wroclaw, Poland specialises in clinical trials of conditions such as Asthma, Colitis ulcerative, Chronic obstructive pulmonary disease, Atrial fibrillation, and other specialisations. This site conducts important research.
The research at Centrum Badan Klinicznych Piotr Napora Lekarze sp.p. focuses on atrial fibrillation and its complications, aiming to reduce the incidence of ischemic stroke in patients who cannot use oral anticoagulants. The trials evaluate the safety and effectiveness of novel agents that may offer an alternative to standard therapy.
With a total of eight ongoing studies, the site in Wroclaw contributes valuable data to cardiovascular research, involving five dedicated investigators.
Investigations target conditions such as ulcerative colitis, cholestasis, and hepatic complications of cirrhosis. Trials test oral therapies like NX‑13 and evaluate long‑term safety of linerixibat for cholestatic pruritus, while also exploring rifaximin to delay hepatic encephalopathy‑related hospitalizations.
The centre’s multidisciplinary team is advancing therapeutic options for liver and intestinal diseases, supporting patients across Poland and Europe.
The site conducts studies on asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis. Research includes biologics such as astegolimab to lower COPD exacerbations, add‑on inhaled treatments like CHF6001 to improve asthma control, and long‑term assessment of BI 1291583 in bronchiectasis patients.
These respiratory trials enhance understanding of disease management and aim to improve quality of life for individuals with chronic lung conditions.
Clinical trials currently enrolling participants at this site.
Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA
PolandA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
PolandStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
PolandStudy of Elafibranor for Adults with Primary Biliary Cholangitis
PolandStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
PolandStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandSafety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study
PolandTitle: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727
PolandStudy of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis
PolandStudy of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
PolandPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
PolandPhase 2b Study of ATH-063 in Adults with Biologic‑Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
